Increased incidence of thyroid cancer in Latina, Italy: A possible role of detection of subclinical disease

Cancer Epidemiology

Volumn 37, Issue 3, 2013, Pages 262-269

  Busco, Susanna ^a   Giorgi Rossi, Paolo ^b   Sperduti, Isabella ^c   Pezzotti, Patrizio ^d   Buzzoni, Carlotta ^e   Pannozzo, Fabio ^a  

^a Cancer Registry   (Italy)

^b PATHOLOGY UNIT   (Italy)

^c REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^d Laziosanità Agency for Public Health Lazio Region   (Italy)

^e Banca dati AIRTUM   (Italy)

Author keywords

Cancer registry; Incidence; Mortality; Over diagnosis; Thyroid cancer

Indexed keywords

ADULT; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER REGISTRY; CANCER SIZE; CYTOLOGY; DIAGNOSTIC PROCEDURE; ECHOGRAPHY; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; HISTOPATHOLOGY; HOSPITAL INFORMATION SYSTEM; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; NECK; OUTPATIENT; PRIORITY JOURNAL; THYROID CANCER; THYROID PAPILLARY CARCINOMA;

ADULT; EARLY DETECTION OF CANCER; FEMALE; HUMANS; INCIDENCE; ITALY; MALE; MIDDLE AGED; THYROID NEOPLASMS;

EID: 84876313764     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2013.02.007     Document Type: Article

References (63)

1. Kilfoy B.A., Zheng T., Holford T.R., Han X., Ward M.H., Sjodin A., et al. International patterns and trends in thyroid cancer incidence, 1973-2002. Cancer Causes & Control 2009, 20:525-531.
2. Reynolds R.M., Weir J., Stockton D.L., Brewster D.H., Sandeep T.C., Strachan M.W. Changing trends in incidence and mortality of thyroid cancer in Scotland. Clinical Endocrinology 2005, 62:156-162.
3. Liu S., Semenciw R., Ugnat A.M., Mao Y. Increasing thyroid cancer incidence in Canada, 1970-1996: time trends and age-period-cohort effects. British Journal of Cancer 2001, 85:1335-1339.
4. Montanaro F., Pury P., Bordoni A., Lutz J.M. Swiss Cancer Registries Network unexpected additional increase in the incidence of thyroid cancer among a recent birth color in Switzerland. European Journal of Cancer Prevention 2006, 15:178-186.
5. Davies L., Welch H.G. Increasing incidence of thyroid cancer in the United States, 1973-2002. Journal of American Medical Association 2006, 295:2164-2167.
6. La Vecchia C., Bosetti C., Lucchini F., Bertuccio P., Negri E., Boyle P., et al. Cancer mortality in Europe. Annals of Oncology 2010, 21:1323-1360.
7. Kent W.D., Hall S.F., Isotalo P.A., Houlden R.L., George R.L., Groome P.A. Increased incidence of differentiated thyroid carcinoma and detection of subclinical disease. Canadian Medical Association Journal 2007, 177:1357-1361.
8. Enewold L., Zhu K., Ron E., Marrogi A.J., Stojadinovic A., Peoples G.E., et al. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiology Biomarkers & Prevention 2009, 18:784-791.
9. Curado M.P., Edwards B., Shin H.R., Bray F., Edwards B., Shin H.R., et al. Cancer incidence in five continents 2007, vol. IX. IARC Scientific Publications No. 160. IARC Press, Lyon, France.
10. AIRTUM Working Group New incidence and mortality data 2003-2005. Epidemiol Prev 2009, 33:1-26.
11. 131I in childhood. Journal of National Cancer Institute 2005, 97:724-732.
12. Nikiforov Y.E. Radiation-induced thyroid cancer: what we have learned from Chernobyl. Endocrine Pathology 2006, 17:307.
13. Nazakov V.S., Demidchik E.P., Asthakova L.N. Thyroid cancer after Chernobyl. Nature 1992, 359:21.
14. Mettler F.A., Bargaven M., Faulkner K., Gilley D.B., Gray J.E., Ibbott G.S., et al. Radiologic and nuclear medicine studies in the United States and Worldwide: frequency, radiation dose, and comparison with other radiation sources_1950-2007. Radiology 2009, 253:520-531.
15. Kleinerman R.A. Cancer risk following diagnostic and therapeutic radiation exposure in children. Pediatric Radiology 2006, 36(Suppl. 2):121-125.
16. Schonfeld S.J., Lee C., Berrington de Gonzalez A. Medical exposure to radiation and thyroid cancer. Clinical Oncology (Royal College of Radiologists) 2011, 23:244-250.
17. 131I with special reference to thyroid cancer. Cancer Detection and Prevention 1991, 15:27-30.
18. Harach H.R., Escalante D.A., Day E.S. Thyroid cancer and thyroiditis in Salta Argentina: a 40 years study in relation to Iodine prophylaxis. Endocrine Pathology 2002, 13:175-181.
19. Burgess J.R., Dwyer T., McArdle K., Tucker P., Shugg D. The changing incidence and spectrum of thyroid carcinoma in Tasmania (1978-1998) during a transition from iodine sufficiency to iodine deficiency. Journal of Clinical Endocrinology and Metabolism 2000, 85:1513-1517.
20. Renehan A.G., Tyson M., Egger M., Heller R.F., Zwahlen M. Body mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008, 371:569-578.
21. Wolin K.Y., Carson K., Colditz G.A. Obesity and cancer. The Oncologist 2010, 15:256-265.
22. Kitara M.C., Platz E.A., Beane Freeman L.E., Hsing A.W., Linet M.S., Park Y., et al. Obesity and thyroid cancer risk among US men and women: a pooled analysis of five prospective studies. Cancer Epidemiology Biomarkers & Prevention 2011, 20:464-472.
23. Engeland A., Tretli S., Akslen L.A., Bjorge T. Body size and thyroid cancer in two million Norwegian men and women. British Journal of Cancer 2006, 95:366-370.
24. Dal Maso L., La Vecchia V., Franceschi S., Preston-Martin S., Ron E., Levi F., et al. A pooled analysis of thyroid cancer study. V. Anthropometric factors. Cancer Causes and Control 2000, 11:137-144.
25. Pellegriti G., De Vatheir F., Scollo C., Attard M., Giordano C., Arena S., et al. Papillary thyroid cancer incidence in the volcanic area of Sicily. Journal of National Cancer Institute 2009, 101:1575-1583.
26. Truong T., Baron-Doubourdieu D., Rougier Y., Guenel P. Role of dietary iodine and cruciferous vegetables in thyroid cancer: a countrywide case-control study in New Caledonia. Cancer Causes and Control 2010, 21:1183-1192.
27. Ward M.H., Kilfoy B.A., Weyer P.J., Anderson K.E., Folsom A.R., Cerhan J.R. Nitrate intake and the risk of thyroid cancer and thyroid disease. Epidemiology 2010, 21389-21395.
28. Navarro Silvera S.A., Miller A.B., Rohan T.E., et al. Risk factors for thyroid cancer: a prospective cohort study. International Journal of Cancer 2005, 116:433-438.
29. Rossing M.A., Voigt L.F., Wicklund K.G., Daling J.R. Reproductive factors and risk of papillary thyroid cancer in women. American Journal of Epidemiology 2000, 151:765-772.
30. Pitz M.R., Sider J.G., Katz R.L., Pollack E.S., Newell G.R. Ethnic patterns of thyroid cancer incidence in the United States, 1973-1981. International Journal of Cancer 1988, 42:549.
31. Pal T., Vogl F.D., Cheppuis P.O., Tsang R., Brierley J., Renard H., et al. Increased risk for non medullary thyroid cancer in the first degree relatives of prevalent cases of non medullary thyroid cancer: a hospital based study. Journal of Clinical Endocrinology and Metabolism 2001, 86:5307-5312.
32. Hemminki K., Eng C., Chen B. Familial risk for non medullary thyroid cancer. Journal of Clinical Endocrinology and Metabolism 2005, 90:5747-5753.
33. Schonfeld S.J., Ron E., Kitahara C.M., Brenner A., Park Y., Sigurdson A.J., et al. Hormonal and reproductive factors and risk of postmenopausal thyroid cancer in the NIH-AARP Diet and Health Study. Cancer Epidemiology 2011, 35:e85-e90.
34. Kabat G.C., Kim M.Y., Wactawski-Wende J., Rohan T.E. Smoking and alcohol consumption in relation to risk of thyroid cancer in postmenopausal women. Cancer Epidemiology 2012, 36:335-340.
35. Harak H.R., Cebalos G.A. Thyroid cancer thyroiditis and dietary iodine: a review based on the Salta Argentina model. Endocrine Pathology 2008, 19:209-220.
36. Leenhardt L., Bernier M.O., Boin-Pineau M.H., Conte Devolx B., Maréchaud R., Niccoli-Sire P., et al. Advances in diagnostic practices affect thyroid cancer incidence in France. European Journal of Endocrinology 2004, 150:133-139.
37. Jemal A., Murray T., Samuels A., Ghafoor A., Ward E., Thun M.J. Cancer statistics 2003. CA: A Cancer Journal for Clinicians 2003, 53:5-26.
38. Oliver S.E., Gunnel D., Donovan J.L. Comparison of trends in prostate cancer mortality in England and Wales and USA. Lancet 2000, 355:1788-1789.
39. Jin J., McHenry C.R. Thyroid incidentaloma. Best Practice and Research: Clinical Endocrinology and Metabolism 2012, 26(1):83-96.
40. Steel S.R., Martin M.J., Mullenix P.S., Azarow K.S., Andersen C.A. The significance of incidental thyroid abnormalities identified during carotid duplex ultrasonography. Archives of Surgery 2005, 140:981-985.
41. Frank L., Quint L.E., Chest C.T. Incidentalomas: thyroid lesions, enlarged mediastinal lymph nodes and lung nodules. Cancer Imaging 2012, 5:41-48.
42. Lohan D.G., Tomasian A., Saleh R., Krishnam M., Finn J.P. Hypervascular thyroid nodules on time resolved MR angiography at RT: radiologic-pathologic correlation. American Journal of Roentgenology 2008, 190:255-260.
43. Bertagna F., Treglia G., Piccardo A., Giubbini R. Diagnostic and clinical significance of F-18-FDG-PET/CT thyroid incidentalomas. Journal of Clinical Endocrinology and Metabolism 2012, 97(11):3966-3975.
44. Dal Maso L., Lise M., Zambon P., Falcini F., Crocetti E., Serraino D., et al. Incidence of thyroid cancer in Italy, 1991-2005: time trends and age period cohort effects. Annals of Oncology 2010, 22:957-963.
45. Storm H.H. Cancer registries in epidemiology research. Cancer Causes and Control 1996, 7:299-301.
46. Papini E., Guglielmi R., Bianchini A., Crescenzi A., Taccogna S., Nardi F., et al. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color Doppler features. Journal of Clinical Endocrinology and Metabolism 2002, 87:1941-4656.
47. Nam-Goong I.S., Kim H.Y., Gong G., Lee H.K., Hong S.J., Kim W.B., et al. Ultrasonography-guided fine needle aspiration of thyroid incidentaloma: correlation with pathologic findings. Clinical Endocrinology 2004, 60:21-28.
48. Wiest P.W., Hartson M.F., Inskip P.D., Crooks L.A., Vela B.S., Telepak R.J., et al. Thyroid palpation versus high resolution thyroid ultrasonography in the detection of nodules. Journal of Ultrasound in Medicine 1998, 17:487-496.
49. Gharib H., Papini E., Paschke R., Duick D.S., Valcavi R., Hegedüs L., et al. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and EuropeanThyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocrine Practice 2010, 16(Suppl 1):1-43.
50. Lise M., Franceschi S., Buzzoni C., Zambon P., Falcini F., Crocetti E., et al. Changes in the incidence of thyroid cancer between 1991 and 2005 in Italy: a geographical analysis. Thyroid 2012, 22:27-34.
51. Clegg L.X., Hankey B.F., Tiwari R., Feuer E.J., Edwards B.K. Estimating average annual percent change in trend analysis. Statistics in Medicine 2009, 28(29):3670-3678.
52. Kilfoy B.A., Devesa S.S., Ward M.H., Zhang Y., Rosenberg P.S., Holford T.R., et al. Gender is an age specific effect modifier for papillary cancer of the thyroid cancer. Cancer Epidemiology Biomarkers & Prevention 2009, 18:1092-1100.
53. Surveillance Epidemiology and End Results (SEER). SEER stat fact sheets: thyroid. Available at: [last accessed 07.02.2013]. http://seer.cancer.gov/statfacts/html/thyro.html.
54. Colonna M., Guizard A.V., Schvartz C., Velten M., Raverdy N., Molinie F., et al. A time trend analysis of papillary and follicular cancer as a function of tumor size: a study of data from six cancer registries in France 1983-2000. European Journal of Cancer 2007, 43(5):891-900.
55. Morris L.G.T., Sikora A.G., Myssiorek D., DeLacure M.D. The basis of racial differences in the incidence of thyroid cancer. Annals of Surgical Oncology 2008, 15:1169-1176.
56. Sprague B.L., Andersen S.W., Trentham-Diez A. Thyroid cancer incidence and socioeconomic indicators of health care access. Cancer Causes and Control 2008, 19:585-593.
57. Teng W., Shan Z., Tang X., Guan H., Li Y., Teng D., et al. Effect on iodine intake on thyroid disease in China. New England Journal of Medicine 2006, 354:2783-2793.
58. Stanbury J.B., Ermans E.A., Bordoux P., Todd C., Oken E., Tonglet R., et al. Iodine induced hyperthyroidism: occurrence and epidemiology. Thyroid 1998, 8:83-100.
59. Rizzo M., Rossi R.T., Bonaffini O., Scisca C., Altavilla G., Calbo L., et al. Increased annual frequency of Hashimoto thyroiditis between years 1988 and 2007 at a cytological unit of Sicily. Annals of Endocrinology (Paris) 2010, 71:625-634.
60. Bülow Pedersen I., Laurberg P., Knudsen N., Jørgensen T., Perrild H., Ovesen L., et al. Increase in incidence of hyperthyroidism predominantly occurs in young people after iodine fortification of salt in Denmark. Journal of Clinical Endocrinology and Metabolism 2006, 19:3830-3834.
61. Kahn C., Simonella L., Sywak M., Boyages S., Ung O., O'Connell D. Pathways to the diagnosis of thyroid cancer in New South Wales: a population based, cross-sectional study. Cancer Causes and Control 2011, [15 October Epub].
62. Mataloni F., Ancona C., Badaloni C., Bucci S., Busco S., Cupellaro E., et al. Cancer incidence and mortality in the color of residents close to the Italian nuclear plants of Borgo Sabotino and Garigliano. Epidemiologia e Prevenzione 2012, 36:253-262.
63. ChenAY, Jemal A., Ward E. Increasing incidence of differentiated thyroid cancer in the United States. Cancer 2009, 115:3801-3807.